Open AccessNon-alcoholic fatty liver disease in a patient with maturity onset diabetes in the young
Author(s) -
Izhaq Masih,
Werner McIlwaine
Publication year - 2009
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr.07.2008.0436
Subject(s) - medicine , fatty liver , liver biopsy , diabetes mellitus , gastroenterology , metformin , liver function tests , cirrhosis , liver disease , alcoholic liver disease , disease , biopsy , endocrinology
We present the case of a 34-year-old man who was first seen in our clinic in 2003. His α-glutamyl transferase (GGT) was raised but the rest of the liver function tests (LFTs) and liver screen were normal. He was diagnosed with maturity onset diabetes of the young (MODY) when he was 21 years old. Abdominal ultrasound showed fatty liver disease. Liver biopsy in 2006 showed non-alcoholic fatty liver disease (NAFLD). This combination has rarely been described in the medical literature. Metformin and gliclizide was started and weight reduction advised. Despite this there is no change in his LFTs, and in 2008, his GGT concentration was even higher. This condition is challenging because of the limited treatment options. Globally, NAFLD is rising and complications such as liver cirrhosis can be seen commonly. NAFLD in a patient with MODY needs thorough attention.